Showing results (71-80 of 307) with videos related to
Sort By:
Pageof 31
Aging and Disease|June 4, 2020
Parkinson Disease and Orthostatic Hypotension in the Elderly: Recognition and Management of Risk Factors for FallsPeter A LeWitt, Steve Kymes, Robert A HauserExpert Review of Neurotherapeutics|April 28, 2005
Ropinirole therapy for Parkinson's diseaseRajesh Pahwa, Kelly E Lyons, Robert A HauserJournal of Neurology, Neurosurgery, and Psychiatry|March 15, 2013
Clinical utility of dopamine transporter single photon emission CT (DaT-SPECT) with (123I) ioflupane in diagnosis of parkinsonian syndromesNin Bajaj, Robert A Hauser, Igor D GrachevArchives of Neurology|December 19, 2006
Factors associated with the development of motor fluctuations and dyskinesias in Parkinson diseaseRobert A Hauser, Michael P McDermott, Susan MessingClinical Parkinsonism & Related Disorders|January 21, 2022
Potential utility of amantadine DR/ER in persons with Parkinson's disease meeting 5-2-1 criteria for device aided therapyRobert A Hauser, Santosh Goud, Andrea E FormellaMovement Disorders : Official Journal of the Movement Disorder Society|December 5, 2002
Clozapine withdrawal symptoms in a Parkinson's disease patientTheresa A Zesiewicz, Sujatha Borra, Robert A HauserJournal of Parkinson'S Disease|December 12, 2013
Droxidopa in patients with neurogenic orthostatic hypotension associated with Parkinson's disease (NOH306A)Robert A Hauser, L Arthur Hewitt, Stuart IsaacsonNeuropsychiatric Disease and Treatment|September 10, 2019
Impact of non-motor symptoms in Parkinson's disease: a PMDAlliance surveyNeal Hermanowicz, Sarah A Jones, Robert A HauserThe American Journal of Medicine|January 4, 2014
An update on Parkinson's disease: improving patient outcomesDaniel Kremens, Robert A Hauser, E Ray DorseyCurrent Neurology and Neuroscience Reports|June 5, 2002
Management of essential tremorTheresa A Zesiewicz, Elmyra Encarnacion, Robert A HauserPageof 31